Home   Categories   Grid

Avacta signs distribution deal for Covid-19 self-test under development

Avacta signs distribution deal for Covid-19 self-test under development

Avacta signs distribution deal for Covid-19 self-test under development

06 June 2020

It has signed an exclusive distribution deal with Medusa19.


NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

04 June 2020

Chesterford Research Park company’s strategy is described as ‘enormously promising’.


AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

25 May 2020

CEO Pascal Soriot says he is ‘quite confident’ potential coronavirus vaccine will work - but admits it's a race to prove it.


Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

20 May 2020

The money will support SMEs looking to access expertise or test products.


Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

15 May 2020

The pharma company is carrying out groundbreaking work to fight Alzheimer’s.


Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

15 May 2020

Its reagents bind to the SARS-CoV-2 viral antigen.


IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

14 May 2020

The Pampisford company will help identify suitable antibodies.


AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

13 May 2020

The Cambridge company says the trials are a validation of its approach.


Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

07 May 2020

The company has joined the platform, which is aimed at accelerating research and trials into potential therapies.


Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

06 May 2020

The work reveals potential targets for tackling the high transmission of the coronavirus.


AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

04 May 2020

They will adopt a non-profit approach during pandemic.


Coronavirus treatments: What we have learned so far about Covid-19

Coronavirus treatments: What we have learned so far about Covid-19

Coronavirus treatments: What we have learned so far about Covid-19

30 April 2020

Following our popular Q&A with Cambridge virologist Dr Jane Greatorex, she discusses what we have learned so far.


AstraZeneca launches trial to assess whether diabetes medicine can be repurposed for Covid-19 patients

AstraZeneca launches trial to assess whether diabetes medicine can be repurposed for Covid-19 patients

AstraZeneca launches trial to assess whether diabetes medicine can be repurposed for Covid-19 patients

29 April 2020

The DARE-19 trial will explore whether the drug dapagliflozin, sold as Farxiga, can reduce serious complications such as organ failure.

1

Mogrify strikes deal with US biopharma Sangamo Therapeutics

Mogrify strikes deal with US biopharma Sangamo Therapeutics

Mogrify strikes deal with US biopharma Sangamo Therapeutics

28 April 2020

The companies have announced a collaboration and licence agreement.


Inivata launches RaDaR test to identify residual disease and relapse in cancer patients

Inivata launches RaDaR test to identify residual disease and relapse in cancer patients

Inivata launches RaDaR test to identify residual disease and relapse in cancer patients

28 April 2020

The Granta Park company says it will initially be used to speed up recruitment in clinical trials and aid their efficacy.


AI VIVO identifies list of 31 drugs that show potential for Covid-19 treatment

AI VIVO identifies list of 31 drugs that show potential for Covid-19 treatment

AI VIVO identifies list of 31 drugs that show potential for Covid-19 treatment

22 April 2020

Cambridge Science Park company is in talks with the government to help accelerate trials.


Amgen agrees 10-year lease on new Cambridge Science Park building

Amgen agrees 10-year lease on new Cambridge Science Park building

Amgen agrees 10-year lease on new Cambridge Science Park building

22 April 2020

The biotech company will move from neighbouring buildings.


AstraZeneca begins clinical trial of blood cancer drug Calquence for Covid-19 patients

AstraZeneca begins clinical trial of blood cancer drug Calquence for Covid-19 patients

AstraZeneca begins clinical trial of blood cancer drug Calquence for Covid-19 patients

20 April 2020

Encouraging early clinical data suggests it could help severely ill patients.


World-first disposable Covid-19 test that gives results in under 10 minutes developed by Sense Biodetection

World-first disposable Covid-19 test that gives results in under 10 minutes developed by Sense Biodetection

World-first disposable Covid-19 test that gives results in under 10 minutes developed by Sense Biodetection

17 April 2020

The handheld, self-contained coronavirus test is being rapidly scaled-up for launch by the Cambridgeshire company.


Healx trains AI to find Covid-19 combination therapies

Healx trains AI to find Covid-19 combination therapies

Healx trains AI to find Covid-19 combination therapies

17 April 2020

The Cambridge company expects results in May.


MOST READ

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More